Radiopharmaceutiques et préparations pharmaceutiques pour le marquage au radiotechnétium (11931)

This tender for radiopharmaceuticals is generally well-structured with clear basic information and a reasonable estimated value. However, it lacks specific details on evaluation criteria and mandatory/eligibility requirements, impacting clarity and completeness.

The tender follows an open procedure (2014/24/ES) and has a clear CPV code. The estimated value is disclosed, and the organization is a public law entity. The submission deadline appears reasonable given the contract duration. No disputes are reported. The primary concern is the lack of specified evaluation criteria, which could lead to procedural ambiguity.

The title and description are clear, and the CPV code is provided. The tender is divided into lots, which is a common practice. However, the absence of explicit mandatory, eligibility, technical, financial, and submission requirements within the provided AI-extracted sections creates a significant gap in clarity for potential bidders.

Most basic information is present, including title, reference, organization, estimated value, and contract duration. The tender documents are listed, although their content summaries are often lacking or indicate 'no content extracted'. The critical missing elements are the detailed requirements (exclusion, eligibility, technical, financial, submission) and evaluation criteria, which are fundamental for a complete tender package.

The tender is open and uses e-procurement, which promotes fairness. The estimated value is disclosed, and the procedure is standard. There are no immediately apparent requirements tailored to specific companies. The division into lots is also a fair practice. The main concern is the lack of transparency regarding evaluation criteria, which could indirectly affect fairness.

The tender is marked as 'E-Procurement', suggesting online submission is possible. The contract duration and estimated value are specified. However, the 'No e-submission' flag in the checks is contradictory and needs clarification. Financing information is not explicitly detailed, and the contract start date is not provided.

Key fields like title, reference, organization, estimated value, and deadlines are populated. The tender is active and has no reported disputes or suspensions. The dates provided (submission deadline, opening date) are logically ordered. The CPV code is present. The main inconsistency arises from the AI-extracted requirements being empty, which clashes with the expectation of a complete tender document.

There is no explicit mention of green procurement, social aspects, innovation, or EU funding in the provided information. This suggests a lack of focus on sustainability criteria within this tender.